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Effect of
Adenosine or Adenosine Triphosphate on
Antidromic Tachycardia
HUAGUI G. LI, MD, PHD, CARLOS A . MORILLO, MD, MARCO ZARDINI, MD,
RANJAN K. THAKUR, MD, FACC, RAYMOND YEE, MD, FACC, GEORGE J . KLEIN, MD, FACC
London, Ontario, Canada
O4setives. This study was designed to determine the effect of
adenosine or adenosine triphosphate (ATP) on antidromic tachy-
ardia.
aaeiigrouad. Adeaoslae and adenosine triphosphate are useful
for dilreatial diagnosis of wide QRS tachyardia . It has been
believed that tachyardia termination caused by these agents is
due to the preferential depressive effect on the atrioveatricular
(AV) mode, whereas their effect on accessory pathways is minimal .
Methods. We studied the effect of adenosine or ATP on the
termination pattern of antidromic tachyardla In 17 patients (10
men, 7 wows; mean age (tSDI 32 t 11 years) with one or more
accessory pathways . Adenosine (6 to 12 mg [a =101) or ATP (8 to
20 ssg (n a 7)) was Injected rapidly through a central venous line
and followed by 10 ml of saline flush after Induction of sustained
antidromic tachyardia .
Rendts. Tahhyardla was terminated In <2 min in 14 patients
(82%) after the injection and remained unchanged In 3 (18%) .
Both adenosine and adenosine triphosphate (ATP) have been
shown to be highly effective for termination of reentrant
tachycardia in which the atrioventricular (AV) node is an
obligate part of the reentrant circuit (1-3) . The relevant
electrophysiologic effect is a brief but potent negative dromo-
tropic action on the AV node, resulting in failure of conduc-
tion . This feature has proved useful in the assessment of wide
QRS tachycardia in which it is generally assumed that termi-
nation of tachycardia signifies that the AV node is a part of
the circuit and that ventricular tachycardia or accessory path-
ways are generally not influenced by adenosine or ATP (4) .
Antidromic AV tachycardia has a reentrant circuit com-
posed of an accessory pathway (anterograde limb) and the normal
AV conduction system (retrograde limb) (5). The effect of
adenosine or ATP on antidromic tachycardia is unknown . We
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Tachycardia termination was due to conduction block in the
accessory pathway (anterograde limb) in seven patients (5070) and
in the AV node (retrograde limb) in another seven . Adenosine or
ATP caused accessory pathway block in seven (88%) of the eight
patients lacking retrograde accessory pathway conduction and in
none of the nine patients having retrograde accessory pathway
conduction (p < 0.01). All five patients with an atriofascicular
accessory pathway and unidirectional anterograde conduction
had tachyardia termination due to anterograde accessory path-
way block after injection of adenosine or ATP.
Confusions. 1) Adenosine or ATP effectively terminates anti-
dromic tachyardia ; 2) the termination is related to block in either
the accessory pathway or the AV node ; 3) accessory pathway block
occurs in patients with a unidirectional, anterogradely conducting
accessory pathway, especially an atriofascicular accessory path-
way.
(! Am Coll Cardiol 1994;24:728-31)
hypothesized that administration of either agent during anti-
dromic AV tachycardia would cause tachycardia termination by
block in the retrograde limb of the reentrant circuit (AV node)
and be useful in the clinical assessment of pre-excited tachycardia .
Methods
Patients. Seventeen patients with one or more accessory
pathways and antidromic tachycardia were studied from 1986
to 1993 (10 men, 7 women; mean age [±SDI 32 ± 11 years,
range 14 to 48), all referred for symptomatic tachycardia . Wide
QRS tachycardia was documented before the electrophysi-
ologic study in 10 patients; in 7 it was induced only in the
electrophysiology laboratory .
Electrophysiologic study. Administration of all antiar-
rhythmic drugs was stopped by a5 half-lives before the study .
After oral and written consent was obtained, the patient was
studied in the postabsorptive state in the electrophysiology
laboratory . Multipolar electrode catheters were percutane-
ously inserted under local anesthesia and positioned in the
coronary sinus, high right atrium, His bundle region and right
ventricular apex. Programmed stimulation was performed as
previously described (6). Surface electrocardiographic (ECG)
leads I, II, III, Vl and V6, as well as bipolar endocardial
electrograms from the coronary sinus, high right atrium, His
0735-1097/94157 .00
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Figure 1. Termination of antidromic tachycardia resulted from antero-
grade accessory conduction block after adenosine injection (6 mg) in a
patient with an atriofascicular accessory pathway. Shown are surface
electrocardiographic leads 1, 11, V, and bipolar endocardiograms from
the high right atrium (FIRA), His bundle region (HBE) and proximal
(CS ) and distal (CS,,) coronary sinus . No apparent change in tachy-
cardia cycle length was observed before termination . The QRS com-
plex during sinus rhythm was normal, as typically observed with
atriofuscicular pathways . H' indicates a retrograde His potential, which
is
usually
close to the QRS onset in atriofascicular pathways .
bundle region and right ventricular apex, were simultaneously
displayed on an oscilloscope, recorded on an ink recorder at
the speed of 100 mm/s and stored on the optical disk of an EP
Lab computer (Biomedical Instrument, Inc ., Toronto) .
Antidromic AV tachycardia was defined by demonstration
of anterograde conduction over an accessory AV pathway and
retrograde conduction over the AV node (5) .
After the induction of sustained antidromic tachycardia
(>5 min), 6 mg of adenosine (n = 10) or 8 mg of ATP (n = 7)
was rapidly injected through the side port of a femoral sheath
and followed by 10 ml of saline flush while the ECG was
continuously monitored. If the tachycardia did not terminate in
10 min, repeat injection at the same dose or twice the initial
dose of adenosine or ATP was carried out . No further injection
was given if doubling of the dose did not terminate tachycardia .
Follow-up. After the study, I I patients underwent success-
ful surgical ablation of the accessory pathway, and 5 had
successful catheter ablation using radiofrequency current ;
1 patient whose tachycardia was well controlled with pro-
pafenone did not undergo the ablation procedure . Repeat
electrophysiologic study was performed I week after the
surgical ablation and 30 min after the radiofrequency ablation .
Statistical analysis. Group values were expressed as mean
value ± SD . A paired t test was performed for comparison
of values within the group and an unpaired t test for analysis of
means between different groups. A Fisher exact test was
performed for analysis of incidence . A p value < 0.05 was
considered significant .
Results
Accessory pathways. There were 21 accessory pathways in
the 17 patients (4 patients had a second accessory pathway) .
There were I I left lateral, 8 right free wall and 2 right posterior












Figure 2 . Termination of antidromic tachycardia resulted from retro-
grade AV node conduction block after injection of adenosine triphos-
phate (8 mg) in a patient with a right free wall accessory pathway . No
apparent change in tachycardia cycle length was observed before the
tachycardia termination . The first sinus beat after tachycardia was
pre-excited and followed by a premature atrial beat that was also
pre-excited . Format and abbreviations as in Figure I .
accessory pathways that had only unidirectional anterograde
conduction (7), and three patients had a single left lateral
accessory pathway with only unidirectional anterograde con-
duction. The accessory pathways in the remaining nine patients
showed bidirectional conduction .
Tachycardia induction. Sustained antidromic tachycardia
was induced by programmed stimulation in the drug-free state
except in one patient who required isoproterenol infusion for
the induction of antidromic tachycardia. The cycle length of
the antidromic tachycardia was 296 ± 30 ins (range 250 to
330). Seven patients also had orthodromic tachycardia in-
duced. The cycle length of the orthodromic tachycardia was
341 ± 42 ms
( '
rage 290 to 420) and was significantly longer
than that of antidromic tachycardia (p < 0 .01) in the same
group of patients .
Tachycardia termination. After the injection of adenosine
or ATP, antidromic tachycardia was terminated in 50 ± 20 s
(range 30 to 100) in 14 patients (82%) and remained sustained
in the remaining 3 (18%) . Antidromic tachycardia was termi-
nated after the first dose in seven patients and required a
second injection at the same dose (n = 1) or twice the initial
dose (n = 6) for termination in seven . Of the 14 patients with
antidromic tachycardia terminated by adenosine or ATP,
tachycardia termination was due to conduction block in the
accessory pathway (anterograde limb) in 7 patients (50%, Fig .
1) and to block in the AV node (retrograde limb) in another 7
(Fig . 2) . Of the eight patients with unidirectional anterograde
conduction by conducting accessory pathways, antidromic
tachycardia termination was due to accessory pathway block in
seven (88%) and to AV node block in one (12%) . All six
patients with accessory pathways showing retrograde conduc-
tion had tachycardia termination by adenosine or ATP due to
conduction block in the AV node rather than the accessory
pathway. Patients with unidirectional anterogradely conduct-
ing pathways had a significantly higher incidence of antidromic
tachycardia termination resulting from accessory pathway con-
duction block after adenosine or ATP injection (p < 0 .01) .
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Of the eight patients with right-sided accessory pathways,
five patients (63%) had tachycardia termination in the acces-
sory pathway. In contrast, only two (22%) of the nine patients
with left-sided accessory pathways had tachycardia termination
in the accessory pathway (p = NS) . All five patients with
atriofascicular accessory pathways (7) showed decremental
conduction (progressive A-delta interval prolongation during
right atrial decremental pacing and extrastimulation) and had
tachycardia termination resulting from accessory pathway con-
duction block . Decremental conduction was not observed in
the two patients with a single unidirectional anterogradely
conducting left lateral accessory pathway . There was no signif-
icant difference in the anterograde effective refractory periods
of the AV node (264 ± 36 vs. 260 ± 30 ms, p = NS) and the
accessory pathway (285 ± 37 vs. 249 ± 36 ms, p = NS), and
the retrograde effective refractory period of the ventricu-
loatrial conduction system (233 ± 45 vs . 265 ± 35 ms . p = NS)
between the group with tachycardia termination in the acces-
sory pathway and the group with tachycardia termination in the
AV node (basic drive cycle length 600 ms) .
Additional accessory pathways. Of the four patients with a
second accessory pathway that was not involved in antidromic
tachycardia, two had concealed left lateral and two had
concealed posteroseptal accessory pathways . The effect of
adenosine or ATP on these pathways could not be determined
because the study was performed only during antidromic
tachycardia .
Follow-up. In 16 of the 17 patients, all accessory pathways
were successfully ablated by surgey (n = 11) or radio-
frequency energy (n = 5) ; the remaining patient, whose
tachycardia involved a single left lateral accessory pathway and
was well controlled with propafenone, did not undergo an
ablation procedure. After accessory pathway ablation, dual AV
node pathway physiology was observed in two patients but
neither had induction of nonsustained or sustained AV node
reentrant tachycardia,
Discussion
Previous studies. Adenosine and ATP are useful in the
diagnosis and treatment of reentrant tachycardia involving the
AV node (1-4).
The termination of a tachycardia involving
the AV node is believed to be mainly due to a preferential
depression of AV node conduction (2,4). In a previous study
from our laboratory (8), adenosine or ATP was found to have
minimal effects on the functional properties of AV accessory
pathways in patients with orthodromic tachycardia . In patients
with antidromic tachycardia, the functional properties of the
accessory pathway and the AV node may be different from
those in patients with only orthodromic tachycardia
(9) . Others
(10) have found shortening of the anterograde effective refrac-
tory period of accessory pathways by adenosine .
Present study. Our present findings demonstrated that
antidromic tachycardia can be terminated by adenosine or
ATP in the majority of patients
. Failure to terminate anti-
dromic tachycardia in the minority of our patients might have
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been due to insufficient dose . It is apparent in this study that
the pattern of tachycardia termination depends on the prop-
erties of the accessory pathway. In patients with unidirectional,
anterogradely conducting accessory pathways, adenosine or
ATP terminated the antidromic tachycardia mainly by causing
conduction block in the accessory pathway . In contrast, in
patients with bidirectional conducting accessory pathways,
adenosine or ATP terminated the tachycardia mainly by
causing conduction block in the AV node. Our five patients
with right-sided atriofascicular accessory pathways all showed
decremental conduction in the accessory pathway and had
antidromic tachycardia termination by adenosine or ATP in
the accessory pathway. However, the absence of retrograde
conduction, rather than decremental conduction, may he a
more significant determinant of the pattern of tachycardia
termination . This possibility is supported by our finding that
two patients with left lateral accessory pathways demonstrating
unidirectional anterograde conduction but no decremental
conduction also had antidromic tachycardia termination result-
ing from accessory pathway conduction block .
Mechanism of induction of accessory pathway block by
adenosine or ATP. It is not clear how adenosine and ATP
induce block in the accessory pathways . Both agents have been
shown to have multiple cardiovascular effects, including nega-
tive chronotropic, dromotropic, vasodilator and antiadrenergic
actions (11) . A preferential depressive effect of adenosine or
ATP on the AV node, which has predominantly calcium-
dependent current in patients with orthodromic tachycardia,
implies that adenosine or ATP may induce tachycardia termi-
nation through the inhibitory effect on calcium current (11) .
Atriofascicular accessory pathways and accessory pathways
with unidirectionally anterograde conduction may have func-
tional properties similar to those of the AV node (7) and thus
respond to adenosine or ATP.
Diagnosis of true antidromic tachycardia . This diagnosis
was confirmed by demonstration of obligatory anterograde
conduction over the accessory pathway and retrograde conduc-
tion over he AV node . Pre-excited tachycardia involving
multiple accessory pathways was excluded by the analysis of
activation patterns. Atrioventricuiar node reentrant tachycar-
dia with bystander anterograde accessory pathway conduction
was excluded by failure to demonstrate AV node reentrant
tachycardia before or after ablation of the accessory pathways .
implications. This study demonstrates that adenosine and
ATP are highly effective in terminating antidromic tachycardia .
However, it also indicates that termination of a wide QRS
tachycardia may not necessarily be the result of AV node
conduction block, even in reentrant tachycardia involving the
AV node. This observation is also supported by recent reports
(12-14) of termination of certain atrial and ventricular tachy-
cardias after injection of adenosine or ATP . The present study
also indicates that the termination pattern of a pre-excited
tachycardia by adenosine or ATP is not useful in differentiating
true antidromic AV tachycardia from AV node reentrant
tachycardia with bystander anterograde accessory pathway
JACC Vol . 24, No. 3
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